title: Recombinant granulocyte colony-stimulating factor increases muscle strength in neuromuscular disorders.
authors: Department of Pediatric Rehabilitation, Medical University of Białystok, Białystok, Poland. Electronic address: kneur2@wp.pl.
authors: Wojciech
authors: W
authors: Kułak
authors: Department of Pediatric Rehabilitation, Medical University of Białystok, Białystok, Poland.
authors: Dorota
authors: D
authors: Sienkiewicz
authors: Department of Pediatric Rehabilitation, Medical University of Białystok, Białystok, Poland.
authors: Bożena
authors: B
authors: Okurowska-Zawada
authors: Department of Pediatric Rehabilitation, Medical University of Białystok, Białystok, Poland.
authors: Grażyna
authors: G
authors: Paszko-Patej
authors: Department of Pediatric Laboratory Diagnostics, Medical University of Białystok, Białystok, Poland.
authors: Janusz
authors: J
authors: Zak
authors: Department of Pediatric Rehabilitation, Medical University of Białystok, Białystok, Poland.
authors: Elżbieta
authors: E
authors: Dmitruk
authors: Department of Pediatric Rehabilitation, Medical University of Białystok, Białystok, Poland.
authors: Janusz
authors: J
authors: Wojtkowski
authors: Department of Pediatric Rehabilitation, Medical University of Białystok, Białystok, Poland.
authors: Kamila
authors: K
authors: Okulczyk
authors: Department of Pediatric Rehabilitation, Medical University of Białystok, Białystok, Poland.
authors: Anna
authors: A
authors: Kaliniowska
authors: Department of Neurology, Medical University of Białystok, Białystok, Poland.
authors: Robert
authors: R
authors: Pogorzelski
mesh_terms: D000293:Adolescent; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007738:Kyphosis / Q000150:complications; D008297:Male; D053580:Muscle Strength / Q000187:drug effects*; D020391:Muscular Dystrophy, Facioscapulohumeral / Q000150:complications / Q000188:drug therapy*; D009465:Neuromuscular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D020336:Paraparesis, Spastic / Q000150:complications; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D012600:Scoliosis / Q000150:complications
chemical_list: D009465:Neuromuscular Agents; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim